MYCO-004

MYCO-004
Clinical data
Other namesMYCO004
Routes of
administration		Transdermal (patch)
Drug classSerotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen

MYCO-004 is a patch-delivered psychedelic tryptamine which is under development for the treatment of psychiatric disorders. It is anticipated to allow for precision dosing and to have a short duration of approximately 2 hours. The drug is being developed by Mydecine. As of December 2021, it is in preclinical research for psychiatric disorders. The exact chemical structure of MYCO-004 does not yet seem to have been disclosed.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.